Cargando…
Antiplatelet therapy following TAVI: time to randomise
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967555/ https://www.ncbi.nlm.nih.gov/pubmed/24399324 http://dx.doi.org/10.1007/s12471-013-0507-7 |
_version_ | 1782309038793424896 |
---|---|
author | Delewi, R. Piek, J. J. |
author_facet | Delewi, R. Piek, J. J. |
author_sort | Delewi, R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3967555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Bohn Stafleu van Loghum |
record_format | MEDLINE/PubMed |
spelling | pubmed-39675552014-03-27 Antiplatelet therapy following TAVI: time to randomise Delewi, R. Piek, J. J. Neth Heart J Editorial Comment Bohn Stafleu van Loghum 2014-01-08 2014-02 /pmc/articles/PMC3967555/ /pubmed/24399324 http://dx.doi.org/10.1007/s12471-013-0507-7 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Editorial Comment Delewi, R. Piek, J. J. Antiplatelet therapy following TAVI: time to randomise |
title | Antiplatelet therapy following TAVI: time to randomise |
title_full | Antiplatelet therapy following TAVI: time to randomise |
title_fullStr | Antiplatelet therapy following TAVI: time to randomise |
title_full_unstemmed | Antiplatelet therapy following TAVI: time to randomise |
title_short | Antiplatelet therapy following TAVI: time to randomise |
title_sort | antiplatelet therapy following tavi: time to randomise |
topic | Editorial Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967555/ https://www.ncbi.nlm.nih.gov/pubmed/24399324 http://dx.doi.org/10.1007/s12471-013-0507-7 |
work_keys_str_mv | AT delewir antiplatelettherapyfollowingtavitimetorandomise AT piekjj antiplatelettherapyfollowingtavitimetorandomise |